Basic Information
Basic information for LINC02223-219-13aa
Peptide Name LINC02223-219-13aa
Genome Position chr5:17926900-17926938[+]
Species Human
Peptide Sequence MCLVYSTHVSVGS
Peptide Length 13
Unique No (LINC02223-201-13aa,LINC02223-202-13aa,LINC02223-203-13aa,LINC02223-205-13aa,LINC02223-206-13aa,LINC02223-207-13aa,LINC02223-208-13aa,LINC02223-211-13aa,LINC02223-212-13aa,LINC02223-213-13aa,LINC02223-214-13aa,LINC02223-215-13aa,LINC02223-216-13aa)
Grand Average of Hydropathicity 0.9846
Relative Molecular Mass 1598.84
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000249937;LINC02223
Transcript ID/Name ENST00000670782;LINC02223-219
Transcript Length 1596
Coding Ability 0.4392
DNA Sequence Corresponding to Peptide ATGTGTCTGGTTTACAGCACTCACGTATCAGTTGGCAGT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :